Renovaro Inc is a biopharmaceutical company. It is engaged in the research and development of pharmaceutical and biological products for the treatment of cancer, HIV, and HBV with the intent to manufacture said products.
Renovaro Inc is a biopharmaceutical company. It is engaged in the research and development of pharmaceutical and biological products for the treatment of cancer, HIV, and HBV with the intent to manufacture said products.
$78.4M
Market Cap • 11/18/20242011
(13 years)
2014
(10 years ago)
NASDAQ
Listing Exchange
Los Angeles
Headquarters • CaliforniaPremium
...and much more!